Volume -
3 , - : 93-97 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Comparison of the Hypochloremic Effects of Erythropoietin and U-74389G. 3 https://doi.org/10.58209/gmjm.3.3.93
URL: http://daneshafarand.org/article-1-240-en.html
URL: http://daneshafarand.org/article-1-240-en.html
Abstract: (706 Views)
Aims: This study calculated the effects on serum chloride levels after treatment with erythropoietin and the antioxidant lazaroid (U-74389G). The calculation was based on the results of 2 preliminary studies, each one of which estimated the certain influence after the respective drug usage in an induced ischemia-reperfusion animal experiment.
Materials & Methods: The 2 main experimental endpoints at which the serum chloride levels were evaluated were the 60th reperfusion min (for groups A, C, and E) and the 120th reperfusion min (for groups B, D, and F). Groups A and B were processed without drugs, C and D after the erythropoietin administration, and E and F after the antioxidant lazaroid administration.
Findings: The first preliminary study of erythropoietin presented a non-significant hypochloremic effect by 0.74+0.55% (p=0.1701). However, the second preliminary study of U-74389G showed a significant hypochloremic effect by 0.75+0.34% (p=0.031). These two studies were co-evaluated since they came from the same experimental setting. The outcome of the co-evaluation was that antioxidant lazaroid is 1.012762-fold (1.011746-1.01378) more hypochloremic than erythropoietin (p=0.0001).
Conclusion: The antioxidant capacities of U-74389G ascribe 1.012762-fold more hypochloremic effects than erythropoietin.
Materials & Methods: The 2 main experimental endpoints at which the serum chloride levels were evaluated were the 60th reperfusion min (for groups A, C, and E) and the 120th reperfusion min (for groups B, D, and F). Groups A and B were processed without drugs, C and D after the erythropoietin administration, and E and F after the antioxidant lazaroid administration.
Findings: The first preliminary study of erythropoietin presented a non-significant hypochloremic effect by 0.74+0.55% (p=0.1701). However, the second preliminary study of U-74389G showed a significant hypochloremic effect by 0.75+0.34% (p=0.031). These two studies were co-evaluated since they came from the same experimental setting. The outcome of the co-evaluation was that antioxidant lazaroid is 1.012762-fold (1.011746-1.01378) more hypochloremic than erythropoietin (p=0.0001).
Conclusion: The antioxidant capacities of U-74389G ascribe 1.012762-fold more hypochloremic effects than erythropoietin.
Article Type: Original Research |
Subject:
Biotechnology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |